Abstract:Background No reliable risk stratification method is available to guide the extent of infectious work-up among hospitalized patients with cirrhosis. Therefore, we aimed to create a risk stratification method for obtaining blood cultures from hospitalized patients with cirrhosis. Methods This was a retrospective cohort study using the Healthcare Cost and Utilization Project - National Readmission Database 2019. Adult patients who were not immunocompromised comprised the final cohort. The primary outcome was the incidence of bacteremia among hospitalized patients with cirrhosis. Secondary outcomes included length of hospital stay, inpatient mortality, and 30-day readmission rate among cirrhosis patients with and without bacteremia. After propensity score matching, the χ2 test was used to assess the primary outcome and inpatient mortality. The Wilcoxon signed-rank test was used to compare the length of hospital stay. Readmission rates were compared via survival analysis. Concomitant bacterial infection, cirrhosis causes, and complications were assessed as potential risk factors for bacteremia using binomial regression. Results The risk ratio (RR) of bacteremia was 1.66 (95% confidence interval (CI): 1.55-1.78) among patients with cirrhosis compared to those without cirrhosis. A concomitant bacterial infection was found to have a strong association with bacteremia in patients with cirrhosis (RR: 3.3, 95% CI: 3.03-3.59). Among cirrhosis patients without concomitant bacterial infection, the incidence of bacteremia was 0.76% (<1%). Among the causes of cirrhosis, primary sclerosing cholangitis was found to have a strong association with bacteremia (RR: 3.88, 95% CI: 2.3-6.04, P < 0.001). Patients with cirrhosis who had bacteremia were hospitalized three days longer than those without bacteremia. There was no difference in inpatient mortality or 30-day readmission rates between cirrhotic patients with and without bacteremia. Conclusion This study suggests that, in the absence of another concomitant bacterial infection and primary sclerosing cholangitis, we can avoid unnecessary blood cultures among immunocompetent patients with cirrhosis. However, given some inherent limitations associated with the database (such as the unavailability of vitals or laboratory values), additional studies are needed to validate its findings.

Risk Factors for Infections in Patients with Cirrhosis

Effect of Antibiotic Prophylaxis on Nosocomial Infection in Liver Cirrhotic Patients with Acute Upper Gastrointestinal Hemorrhage

Epidemiological Investigation of Non-Fermentative Bacterial Infection in Cirrhotic Patients.

Characteristics and Related Factors of Bacterial Infection Among Patients With Cirrhosis

Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.

Infections in Cirrhosis

Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis

Pathogen Profile and Drug Resistance Analysis of Spontaneous Peritonitis in Cirrhotic Patients

The analysis of risk factors for pulmonary infections in patients with alcoholic cirrhosis

Infections complicating cirrhosis

Risk Factors for Clostridium Difficile Infection in Cirrhotic Patients.

Interobserver Agreement for Classifying Infections in Patients with Decompensated Cirrhosis Based on Centers for Disease Control and Prevention Criteria

Community- or Healthcare-Associated Bacterial Infections Increase Long-Term Mortality in Patients With Acute Decompensation of Cirrhosis.

[Risk factors and nutritional status analysis in patients with liver cirrhosis and concomitant chronic periodontitis]

Analysis of Correlative Factors in Infection of Liver Transplant Recipients.

Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity

Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure

Acute Decompensation Events Differentially Impact the Risk of Nosocomial Infections and Short-Term Outcomes in Patients with Cirrhosis

Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda

Risk factors predicting nosocomial, healthcare-associated and community-acquired infection in spontaneous bacterial peritonitis and survival outcome

Prudent Use of Blood Cultures for Hospitalized Patients With Cirrhosis